|
US5459128A
(en)
*
|
1993-11-12 |
1995-10-17 |
Dana-Farber Cancer Institute |
Human monocyte chemoattractant protein-1 (MCP-1) derivatives
|
|
US5716394A
(en)
|
1994-04-29 |
1998-02-10 |
W. L. Gore & Associates, Inc. |
Blood contact surfaces using extracellular matrix synthesized in vitro
|
|
US6774278B1
(en)
|
1995-06-07 |
2004-08-10 |
Cook Incorporated |
Coated implantable medical device
|
|
US5922554A
(en)
|
1995-10-30 |
1999-07-13 |
The Regents Of The University Of California |
Inhibition of cellular uptake of cholesterol
|
|
EP0880586A1
(en)
|
1996-02-01 |
1998-12-02 |
The University Of Florida |
Lyst1 and lyst2 gene compositions and methods of use
|
|
GB9716657D0
(en)
*
|
1997-08-07 |
1997-10-15 |
Zeneca Ltd |
Chemical compounds
|
|
CA2325562A1
(en)
|
1998-04-03 |
1999-10-14 |
Curagen Corporation |
Lyst protein complexes and lyst interacting proteins
|
|
US7008645B2
(en)
|
1998-07-14 |
2006-03-07 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Method of inhibiting restenosis using bisphosphonates
|
|
US6984400B2
(en)
|
1998-07-14 |
2006-01-10 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Method of treating restenosis using bisphosphonate nanoparticles
|
|
US6184226B1
(en)
|
1998-08-28 |
2001-02-06 |
Scios Inc. |
Quinazoline derivatives as inhibitors of P-38 α
|
|
FR2785812B1
(fr)
*
|
1998-11-16 |
2002-11-29 |
Commissariat Energie Atomique |
Protheses bioactives, notamment a proprietes immunosuppressives, antistenose et antithrombose, et leur fabrication
|
|
US7763580B2
(en)
|
1999-01-05 |
2010-07-27 |
University Of Utah Research Foundation |
Methods for treating conditions associated with the accumulation of excess extracellular matrix
|
|
GB9902455D0
(en)
*
|
1999-02-05 |
1999-03-24 |
Zeneca Ltd |
Chemical compounds
|
|
DE60001229T2
(de)
|
1999-04-09 |
2003-10-30 |
Smithkline Beecham Corp., Philadelphia |
Triarylimidazole
|
|
CN1378445B
(zh)
*
|
1999-08-06 |
2013-02-06 |
得克萨斯系统大学评议会 |
药物释放生物可降解纤维植入物
|
|
US20020125613A1
(en)
|
2001-03-08 |
2002-09-12 |
Cominsky Kenneth D. |
Mandrel fabrication for cobond assembly
|
|
US6660034B1
(en)
*
|
2001-04-30 |
2003-12-09 |
Advanced Cardiovascular Systems, Inc. |
Stent for increasing blood flow to ischemic tissues and a method of using the same
|
|
AU2002309461B2
(en)
*
|
2001-06-15 |
2008-07-17 |
A*STAR*: Agency for Science, Technology and Research |
Biofunctional fibers
|
|
US20030064965A1
(en)
|
2001-10-02 |
2003-04-03 |
Jacob Richter |
Method of delivering drugs to a tissue using drug-coated medical devices
|
|
MXPA04003906A
(es)
|
2001-10-25 |
2005-02-17 |
Wisconsin Alumni Res Found |
Endoprotesis vacular o injerto revestido o impregnado con inhibidores de quinasa de tirosina de proteina y metodo para utilizar los mismos.
|
|
US20030082148A1
(en)
*
|
2001-10-31 |
2003-05-01 |
Florian Ludwig |
Methods and device compositions for the recruitment of cells to blood contacting surfaces in vivo
|
|
US20040063654A1
(en)
|
2001-11-02 |
2004-04-01 |
Davis Mark E. |
Methods and compositions for therapeutic use of RNA interference
|
|
GB0217786D0
(en)
|
2002-07-31 |
2002-09-11 |
Glaxo Group Ltd |
Compounds
|
|
US20050163821A1
(en)
*
|
2002-08-02 |
2005-07-28 |
Hsing-Wen Sung |
Drug-eluting Biodegradable Stent and Delivery Means
|
|
CA2496419A1
(en)
*
|
2002-08-19 |
2004-02-26 |
Abgenix, Inc. |
Antibodies directed to monocyte chemo-attractant protein-1 (mcp-1) and uses thereof
|
|
AU2003290734A1
(en)
|
2002-11-27 |
2004-06-23 |
Eli Lilly And Company |
Novel compounds as pharmaceutical agents
|
|
JP2007525423A
(ja)
*
|
2003-02-20 |
2007-09-06 |
プロテオン セラピューティクス，インコーポレーテッド |
生体導管の疾患を治療および予防するための方法
|
|
CA2517720A1
(en)
|
2003-03-11 |
2004-09-23 |
Pfizer Products Inc. |
Pyrazine compounds as transforming growth factor (tgf) inhibitors
|
|
WO2004112710A2
(en)
|
2003-06-17 |
2004-12-29 |
Millennium Pharmaceuticals, Inc. |
COMPOSITIONS AND METHODS FOR INHIBITING TGF-ß
|
|
WO2005013915A2
(en)
|
2003-08-08 |
2005-02-17 |
The Regents Of The University Of California |
Novel indications for transforming growth factor-beta regulators
|
|
WO2005032611A2
(de)
|
2003-09-29 |
2005-04-14 |
Hemoteq Gmbh |
Biokompatible, biostabile beschichtung von medizinischen oberflächen
|
|
WO2005049105A2
(en)
*
|
2003-11-10 |
2005-06-02 |
Angiotech International Ag |
Medical implants and anti-scarring agents
|
|
US6997989B2
(en)
*
|
2003-12-08 |
2006-02-14 |
Boston Scientific Scimed, Inc. |
Medical implant processing chamber
|
|
AU2004309083B2
(en)
|
2003-12-30 |
2010-11-11 |
Augustinus Bader |
Tissue regeneration method
|
|
US7244444B2
(en)
|
2004-03-31 |
2007-07-17 |
Cook Incorporated |
Graft material, stent graft and method
|
|
US7763065B2
(en)
|
2004-07-21 |
2010-07-27 |
Reva Medical, Inc. |
Balloon expandable crush-recoverable stent device
|
|
JP5144000B2
(ja)
|
2004-08-25 |
2013-02-13 |
太陽化学株式会社 |
形質転換増殖因子β抑制用組成物
|
|
CA2578630A1
(en)
|
2004-08-31 |
2006-03-09 |
Wen-Cherng Lee |
Pyrimidinylimidazoles as tgf-beta inhibitors
|
|
WO2006099332A2
(en)
*
|
2005-03-11 |
2006-09-21 |
Wake Forest University Health Sciences |
Production of tissue engineered digits and limbs
|
|
WO2006102102A2
(en)
|
2005-03-17 |
2006-09-28 |
Marshfield Clinic |
Tgf-beta modulators and methods for using the same
|
|
KR20080072912A
(ko)
*
|
2005-11-15 |
2008-08-07 |
오르버스네이치 메디칼 인코포레이티드 |
약물을 용리하는 이식가능한 의료 장치를 사용한 전구 내피세포 포획
|
|
EP2049141A4
(en)
|
2006-07-21 |
2011-10-26 |
Promics Pty Ltd |
TREATMENT OF INTIMAL HYPERPLASIA AND ASSOCIATED DISEASES
|
|
WO2008039521A2
(en)
*
|
2006-09-26 |
2008-04-03 |
Nmt Medical, Inc. |
Method for modifying a medical implant surface for promoting tissue growth
|
|
CN101528752A
(zh)
|
2006-10-16 |
2009-09-09 |
辉瑞产品公司 |
治疗性吡唑基噻吩并吡啶
|
|
US7959942B2
(en)
|
2006-10-20 |
2011-06-14 |
Orbusneich Medical, Inc. |
Bioabsorbable medical device with coating
|
|
RU2452517C2
(ru)
|
2007-01-30 |
2012-06-10 |
Хемотек Аг |
Биоразрушаемое средство для поддержания просвета сосудов
|
|
KR100932688B1
(ko)
|
2007-07-06 |
2009-12-21 |
한국과학기술연구원 |
인공혈관용 이중막 구조의 튜브형 다공성 스캐폴드 및 그의제조방법
|
|
US20090043378A1
(en)
*
|
2007-08-10 |
2009-02-12 |
Medtronic Vascular, Inc. |
Biocompatible Polymer System for Extended Drug Release
|
|
US8277832B2
(en)
|
2007-10-10 |
2012-10-02 |
The University Of Kansas |
Microsphere-based materials with predefined 3D spatial and temporal control of biomaterials, porosity and/or bioactive signals
|
|
US7824601B1
(en)
|
2007-11-14 |
2010-11-02 |
Abbott Cardiovascular Systems Inc. |
Process of making a tubular implantable medical device
|
|
WO2009089324A1
(en)
|
2008-01-08 |
2009-07-16 |
Yale University |
Compositions and methods for promoting patency of vascular grafts
|
|
US20100092534A1
(en)
*
|
2008-10-10 |
2010-04-15 |
Medtronic Vascular, Inc. |
Combination Local Delivery Using a Stent
|
|
US20100129414A1
(en)
|
2008-11-24 |
2010-05-27 |
Medtronic Vascular, Inc. |
Bioactive Agent Delivery Using Liposomes in Conjunction With Stent Deployment
|
|
RU2440128C1
(ru)
|
2010-05-17 |
2012-01-20 |
Государственное образовательное учреждение дополнительного профессионального образования "Санкт-Петербургская медицинская академия последипломного образования Федерального агентства по здравоохранению и социальному развитию" (ГОУ ДПО СПбМАПО Росздрава) |
Способ комплексной патогенетической терапии острых форм вирусного гепатита в и микст-гепатитов (в+с, в+d, в+с+d)
|
|
EP2571977B1
(en)
|
2010-05-17 |
2020-01-08 |
Yale University, Inc. |
System for seeding cells onto three dimensional scaffolds
|
|
US9090863B2
(en)
|
2010-05-17 |
2015-07-28 |
Pall Corporation |
System for seeding cells onto three dimensional scaffolds
|
|
US20130013083A1
(en)
|
2011-01-06 |
2013-01-10 |
Humacyte |
Tissue-Engineered Constructs
|
|
US10227568B2
(en)
|
2011-03-22 |
2019-03-12 |
Nanofiber Solutions, Llc |
Fiber scaffolds for use in esophageal prostheses
|
|
WO2013003157A1
(en)
|
2011-06-28 |
2013-01-03 |
Yale University |
Cell-free tissued engineered vascular grafts
|
|
EP3950019A1
(en)
|
2013-03-15 |
2022-02-09 |
Nanofiber Solutions, LLC |
Biocompatible fiber textiles for implantation
|
|
WO2014197790A1
(en)
|
2013-06-06 |
2014-12-11 |
University Of Maryland, College Park |
Compositions and methods for making biodegradable structures
|
|
CA3007631A1
(en)
|
2015-12-11 |
2017-06-15 |
Research Institute At Nationwide Children's Hospital |
Optimized patient specific non-linear tissue engineered vascular grafts
|